Kedrion is a biotechnology company specializing in the development, production and distribution of plasmaderivatives.
It was founded in 2001 following the rationalization and optimization of operations in other companies involved in the sector since the 1960s. Kedrion has acquired corporate assets that guarantee it a leading role in Europe and the world.
In Italy, Kedrion is the main reference point for the National Health Service as regards the production of plasma-derived drugs.
Moreover, its skills are also put to use in strategic partnerships with overseas health services.
The quality of its products, its continuous commitment to research and development, its consistent industrial capacity and its consolidated presence on the national and international market are the company's main areas of competitiveness